ArticleBreast cancer research and treatment2022

The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth.

Yayun Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.